New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: Destruction from above

Matrix Biology

Volumn 17, Issue 8-9, 1998, Pages 585-601

  Konttinen, Yrjö T ^a,b,g   Ceponis, Arnoldas ^a,c   Takagi, Michiaki ^e   Ainola, Mari ^b   Sorsa, Timo ^b   Sutinen, Meeri ^d   Salo, Tuula ^d   Ma, Jian ^b   Santavirta, Seppo ^a   Seiki, Motoharu ^f  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ORTON Invalid Foundation   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e YAMAGATA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Matrix metalloproteinase; Rheumatoid arthritis; Substrate specificity

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGENASE; GELATINASE A; GELATINASE B; NEUTROPHIL COLLAGENASE; REGULATOR PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; BONE; CARTILAGE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; DENSITOMETRY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; PANNUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; STROMA CELL; SYNOVIUM; VASCULAR ENDOTHELIUM;

EID: 13044296013     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(98)90110-X     Document Type: Article

References (54)

1. Aimes, R.T. and Quigley, J.P.: Matrix metalloproteinase-2 is an interstitial collagenase. J. Biol. Chem. 270: 5872-5876, 1995.
2. Allard, S.A., Bayliss, M.T. and Maini, R.: The synovium-cartilage junction of the normal human knee. Implications for joint destruction and repair. Arthritis Rheum. 33: 1170-1179, 1990.
3. Allard, S.A., Muirden, K.D. and Maini, R.N.: Correlation of histopathological features of pannus with patterns of damage in different joints in rheumatoid arthritis. Ann. Rheum. Dis. 50:278-283, 1991.
4. Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, D., Greenwald, R., Hochberg, M., Howell, D., Kaplan, D., Koopman, W., Longley III, S., Mankin, H., McShane, D.J., Medsger, T., Jr., Meenan, R., Mikkelsen, W., Moskowitz, R., Murphy, W., Rothschild, B., Segal, M., Sokoloff, L. and Wolfe, F.: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 29: 1039-1049, 1986.
5. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S.,Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., Medsger, T.A. Jr. , Mitchell, D.M., Neustadt, D.H., Pinals, R.S., Schaller, J.G., Sharp, J.T., Wilder, R.L. and Hunder, G.G.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324, 1988.
6. Autio-Harmainen, H., Hurskainen, T., Niskasaari, K., Höyhtyä, M. and Tryggvason, K.: Simultaneous expression of 70 kilodalton type IV collagenase and type IV collagen a1 (IV) chain genes by cells of early human placenta and gestational endometrium. Lab. Invest. 67: 191-200, 1992.
7. Bergmann, U., Tuuttila, A., Stetler-Stevenson, W.G. and Tryggvason, K.: Autolytic activation of recombinant human 72 kilodalton type IV collagenase. Biochemistry 34: 2819-2825, 1995.
8. Cawston, T.E., Curry, V.A., Clark, I.M. and Hazleman, B.L.: Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase. Biochem. J. 269: 183-187, 1990.
9. Cole, A.A., Chubinskaya, S., Schumacher, B., Huch, K., Szabo, G., Yao, J., Mikecz, K., Hasty, K.A. and Kuettner, K.E.: Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J. Biol. Chem. 271: 11023-11026, 1996.
10. De Souza, S.J., Pereira, H.M., Jacchieri, S. and Brentani, R.R.: Collagen/collagenase interaction: does the enzyme mimic the conformation of its own substrate? FASEB J. 10: 927-930, 1996.
11. Fassbender, H.G. and Gay, S.: Synovial processes in rheumatoid arthritis. Scand. J. Rheumatol. 76(Suppl.): 1-7, 1988.
12. Fosang, A.J., Last, K., Knäuper, V., Murphy, G. and Neame, P.J.: Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380: 17-20, 1996.
13. Freije, J.M.P., Díez-Itza, L, Balbin, M., Sánchez, L.M., Blasco, R., Tolivia, J. and López-Otín, C.: Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269: 16766-16773, 1994.
14. Gay, S. and Gay, R.E.: Cellular basis and oncogene expression of rheumatoid joint destruction. Rheumatol. Int. 9: 105-113, 1989.
15. Hasty, K.A., Jeffrey, J.J., Hibbs, M.S. and Welgus, H.G.: The collagen substrate specificity of human neutrophil collagenase. J. Biol. Chem. 262: 10048-10052, 1987.
16. Höyhtyä, M., Fridman, R., Komarek, D., Porter-Jordan, K., Stetler-Stevenson, W.G., Liotta, L. and Liang, C.-M.: Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int. J. Cancer 56: 500-505, 1994.
17. Höyhtyä, M., Myllylä, R., Piuva, J., Kivirikko, K.I. and Tryggvason, K.: Monoclonal antibodies to human prolyl 4-hydroxylase. Eur. J. Biochem. 141: 477-482, 1984.
18. Höyhtyä, M., Turpeenniemi-Hujanen, T., Stetler-Stevenson, W., Krutzsch, H., Tryggvason, K. and Liotta, L.A.: Monoclonal antibodies to type IV collagenase recognize a protein with limited sequence homology to interstitial collagenase and stromelysin. FEBS Lett. 233: 109-113, 1988.
19. Immert-Buck, M.R., Emonard, H.P., Corcoran, M.L., Krutzsch, H.C., Foidart, J.M. and Stetler-Stevenson, W.G.: Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett. 364:28-32, 1995.
20. Kleiner, D.E., Jr., Tuuttila, A., Tryggvason, K. and Stetler-Stevenson, WG.: Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochemistry 32: 1583-1592, 1993.
21. Knäuper, V., López-Otin, C., Smith, B., Knight, G. and Murphy, G.: Biochemical characterization of human collagenase-3. J. Biol. Chem. 271: 1544-1550, 1996a.
22. Knäuper, V., Will, H., López-Otín, C., Smith, B., Atkinson, S.J., Stanton, H., Hembry, R.M. and Murphy, G.: Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J. Biol. Chem 271: 17124-17131, 1996b.
23. Kobayashi, I. and Ziff, M.: Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum. 18: 475-483, 1975.
24. Kolkenbrock, H., Hecker-Kia, A., Orgel, D., Ruppitsch, W. and Ulbrich, N.: Activity of ternary gelatinase-A-TIMP-2-matrix metalloproteinase complexes. Biol. Chem. H-S 375: 589-595, 1994.
25. Kolkenbrock, H., Orgel, D., Hecker-Kia, A., Noack, W. and Ulbrich, N.: The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72 kDa progelatinase is a metalloproteinase inhibitor. Eur. J. Biochem. 198: 775-781, 1991.
26. Konttinen, Y.T., Lindy, O., Suomalainen, K., Ritchlin, C., Saari, H., Vauhkonen, M., Lauhio, A., Santavirta, S. and Sorsa, T.: Substrate specificity and activation mechanisms of collagenase from human rheumatoid synovium. Matrix 11: 395-403, 1991.
27. Konttinen, Y.T., Nykänen, P., Nordström, D., Saari, H., Sandelin, J., Santavirta, S. and Kouri, T.: DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study. J. Rheumatol. 16: 339-345, 1989.
28. Lewalle, J.M., Munaut, C., Pichot, B., Cataldo, D., Baramova, E. and Foidart, J.M.: Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J. Cell. Physiol. 165: 475-483, 1995.
29. Lindy, O., Konttinen, Y.T., Sorsa, T., Ding, Y., Santavirta, S., Ceponis, A. and López-Otín, C.: MMP-13 (collagenase-3) in human rheumatoid synovium. Arthritis Rheum. 40: 1391-1399, 1997.
30. Lohi, J., Lehti, K., Westermarck, J., Kähäri, V.-M. and Keski-Oja, J.: Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur. J. Biochem. 239:239-247, 1996.
31. Micklem, K., Rigney, E., Cordell, J., Simmons, D., Stross, P., Turley, H., Seed, B. and Mason, D.: A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies. Brit. J. Haematol. 73: 6-11, 1989.
32. Miller, E.J. and Rhodes, R.K.: Preparation and characterization of the different types of collagen. Meth. Enzymol. 82: 33-64, 1982.
33. Mitchell, P.G., Magna, H.A., Reeves, L.M., Loprestimorrow, L.L., Yocum, S.A., Rosner, P.J., Geoghegan, K.E and Hambor, J.E.: Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97: 761-768, 1996.
34. Ohuchi, E, Imai, K., Fujii, Y., Sato, H., Seiki, M. and Okada, Y: Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272: 2446-2451, 1997.
35. Pei, D. and Weiss, S.J.: Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271: 9135-9140, 1996.
36. Pirilä, L.: Cell adhesion receptors in rheumatoid synovial lining (thesis). Ann. Universitatis Turkuensis (Series D) 253: 1-79, 1996.
37. Reboul, P., Pelletier, J.-P., Tardif, G., Cloutier, J.M. and Martel-Pelletier, J.: The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J. Clin. Invest. 97: 2011-2019, 1996.
38. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M.: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994.
39. Sawicki, G., Salas, E., Murat, J., Miszta-Lane, H. and Radomski, M.W.: Release of gelatinase A during platelet activation mediates aggregation. Nature 386: 616-619, 1997.
40. Shiozawa, S., Shiozawa, K. and Fujita, T.: Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus. Arthritis Rheum. 26: 472-478, 1983.
41. Stetler-Stevenson, W.G., Brown, P.D., Onisto, M., Levy, A.T. and Liotta, L.A.: Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265; 13933-13938, 1990.
42. Stetler-Stevenson, W.G., Krutzsch, H.C. and Liotta, E.A.: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264: 17374-17378, 1989.
43. Stetler-Stevenson, W.G., Krutzsch, H.C. and Liotta, L.A.: TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family. Matrix 1: 299-309, 1992.
44. Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant, G. A. and Goldberg G.I.: Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270: 5331-5338, 1995.
45. Takagi, M., Santavirta, S., Ida, H., Ishii, M., Akimoto, K., Saotome, K. and Konttinen, Y.T.: The membrane-type-matrix metalloproteinase/ matrix metalloproteinase-2/ tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses. Lab. Invest. 78: 735-742, 1998.
46. Theret, N., Mussa, O., L-Helgoualc'h, A. and Clement, B.: Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes. Am. J. Pathol. 150: 51-58, 1997.
47. Turto, H., Lindy, S., Uitto, V.-J., Wegelius, O. and Uitto, J.: Human leukocyte collagenase: characterization of enzyme kinetics by a new method. Anal. Biochem. 83: 557-569, 1977.
48. Vartio, T. and Baumann, M.: Human gelatinase/type IV procollagenase is a regular plasma component. FEBS Lett. 255: 285-289, 1989.
49. Welgus, H.G., Jeffrey, J.J. and Eisen, A.Z.: The collagen substrate specificity of human skin fibroblast collagenase. J. Biol. Chem. 256: 9511-9515, 1981.
50. Woolley, D.E., Crossley, M.J. and Evanson, J.M.: Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum. 20:1231-1239, 1977.
51. Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G.N., Seiki, M., Sato, H., Gokaslan, Z.L., Liotta, L.A., Nicolson, G.L., and Rao, J.S.: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56; 384-392, 1996.
52. Zucker, S., Lysik, R.M., Zarrabi, H.M., Moll, U., Tickle, S.P., Stetler-Stevenson, W., Baker, T.S. and Docherty, A.J.P.: Plasma assay of matrix metalloproteinases (MMPs) and MMP-inhibitor complexes in cancer. Potential use in predicting metastasis and monitoring treatment. Ann. NY Acad. Sci. 732: 248-262, 1994.
53. Zvaifler, N.J. and Firestein, G.S.: Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum. 37: 783-789, 1994.
54. Zvaifler, N.J., Tsai, V., Alsalameh, S., von Kempis, J., Firestein, G.S. and Lotz, M.: Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions. Am. J. Pathol. 150; 1125-1138, 1997.